QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer
Clinical trial NCT07156682 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07156682
- Sponsor
- Qilu Hospital of Shandong University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2027-06-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.